Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$66.66 - $111.74 $13.9 Million - $23.3 Million
-208,333 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$45.89 - $72.67 $5.31 Million - $8.41 Million
-115,705 Reduced 35.71%
208,333 $15.1 Million
Q2 2020

Aug 14, 2020

SELL
$26.36 - $49.86 $26.1 Million - $49.5 Million
-991,962 Reduced 75.38%
324,038 $16.2 Million
Q1 2020

May 15, 2020

BUY
$17.27 - $40.17 $22.7 Million - $52.9 Million
1,316,000 New
1,316,000 $39.3 Million
Q3 2019

Nov 14, 2019

SELL
$25.38 - $34.89 $25.5 Million - $35 Million
-1,002,834 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$17.75 - $27.58 $5.68 Million - $8.83 Million
-320,000 Reduced 24.19%
1,002,834 $27.7 Million
Q1 2019

May 15, 2019

BUY
$11.34 - $20.62 $791,917 - $1.44 Million
69,834 Added 5.57%
1,322,834 $27.3 Million
Q4 2018

Feb 14, 2019

BUY
$12.32 - $24.38 $15.4 Million - $30.5 Million
1,253,000 New
1,253,000 $17.5 Million
Q3 2018

Nov 14, 2018

SELL
$18.82 - $28.96 $20.3 Million - $31.3 Million
-1,080,829 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$8.79 - $19.98 $18.5 Million - $41.9 Million
-2,099,171 Reduced 66.01%
1,080,829 $20.3 Million
Q1 2018

May 15, 2018

BUY
$9.0 - $11.95 $2.33 Million - $3.1 Million
259,144 Added 8.87%
3,180,000 $29.5 Million
Q4 2017

Feb 14, 2018

BUY
$8.99 - $14.31 $6.65 Million - $10.6 Million
739,314 Added 33.89%
2,920,856 $26.3 Million
Q3 2017

Nov 13, 2017

BUY
$8.02 - $13.33 $17.5 Million - $29.1 Million
2,181,542
2,181,542 $28.1 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.3B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Deerfield Management Company, L.P. (Series C) Portfolio

Follow Deerfield Management Company, L.P. (Series C) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.